Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RALOX vs CAPOX with Bevacizumab in Advanced Colorectal Cancer
NCT03813641Phase 2Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- Jan 2019
- Primary completion
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of raltitrexed in colorectal cancer (CRC), sponsored by Shenzhen People's Hospital. Status: unknown.
02
Drugs
raltitrexed
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT03813641.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03813641.